SA
STOCK ALARM
STOCK ALARM
SA
Menu
Demo
Log In
VRTX
(VRTX)
VRTX
Overview
Notebook
Intelligence
Chart
History
Fundmntls
TTM
Earnings
Analysts
News
Financials
Segments
Insiders
Institl.
DCF
Peers
Key Metrics
Explore More
S&P 500 Screener
Filter and sort all 500 stocks
Market Movers
Today's biggest gainers and losers
Market Heatmap
Visual sector performance
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.
Home
Screener
Alerts
Search
More
Vertex Pharmaceuticals Incorporated
(VRTX)
$499.65
▲
8.31 (1.69%)
Chart
Share
Post on X
VRTX
Vertex Pharmaceuticals Incorporated
(VRTX)
NASDAQ
$499.65
▲
8.31 (1.69%)
Chart Studio
Share
VRTX
As of
2025
• vs 2024
Annual
Quarterly
Core Metrics
Market Cap
$115.92B
+11.8%
P/E Ratio
29.32
+115.1%
P/S Ratio
9.60
+2.0%
ROE
21.18%
+748.9%
ROIC
18.12%
+588.2%
FCF Yield
2.76%
+461.5%
Debt/Equity
0.21
+95.1%
Current Ratio
2.90
+7.8%
Interest Coverage
357.95x
+4803.0%
Per Share
Revenue/Share
$47.22
+10.3%
Net Income/Share
$15.46
+843.3%
Operating CF/Share
$14.20
+842.4%
Free CF/Share
$12.49
+507.0%
Cash/Share
$25.85
+8.9%
Book Value/Share
$73.00
+14.6%
Tangible Book/Share
$67.08
+19.2%
Equity/Share
$73.00
+14.6%
Interest Debt/Share
$15.24
+120.4%
Valuation
Market Cap
$115.92B
+11.8%
Enterprise Value
$114.72B
+13.7%
P/E Ratio
29.32
+115.1%
P/S Ratio
9.60
+2.0%
P/OCF Ratio
31.92
+115.2%
P/FCF Ratio
36.30
+127.7%
P/B Ratio
6.21
-1.7%
P/TB Ratio
6.21
-1.7%
EV/Sales
9.50
+3.8%
EV/EBITDA
23.59
-88.6%
Profitability
Earnings Yield
3.41%
+760.2%
FCF Yield
2.76%
+461.5%
ROE
21.18%
+748.9%
ROIC
18.12%
+588.2%
Return on Tangible Assets
16.05%
+717.9%
Capital Allocation
CapEx/OCF
12.05%
+119.9%
CapEx/Revenue
3.62%
+34.2%
CapEx/Depreciation
2.09
+45.2%
SBC/Revenue
5.68%
-10.4%
Balance Sheet
Debt/Equity
0.21
+95.1%
Debt/Assets
0.15
+91.3%
Net Debt/EBITDA
-0.25
+95.7%
Current Ratio
2.90
+7.8%
Interest Coverage
357.95x
+4803.0%
Income Quality
0.92
-0.1%
Efficiency
Days Sales Outstanding
62 days
+16.4%
Days Payables Outstanding
93 days
-5.3%
Days Inventory
341 days
+18.5%
Receivables Turnover
5.88x
-14.1%
Payables Turnover
3.91x
+5.6%
Inventory Turnover
1.07x
-15.6%
Special Valuations
Graham Number
$159.35
Graham Net-Net
$5.93
-15.2%